The 5th Vaccine Development Research Forum

September 19, 2019


  • Nucleoside-modified mRNA-lipid nanoparticle vaccine platform for infectious diseases.
  • What’s new in TB vaccine development
  • VLP-based vaccine/therapeutics in the context of allergic diseases
  • Specific delivery of therapeutic mRNA to different cell types and organs using targeted LNPs
  • Cytomegalovirus and risk of Tuberculosis disease
Posted in Events